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Lung cancer is the most common cause of cancer
deaths in both men and women. Adenocarcinoma repre-
sents about 28% of the NSCLC cases in men and 42% in
women. EGFR is a member of the ERBB family of tyro-
sine kinases (TK). EGFR mutations are more frequently
observed in female, non-smokers, East-Asian and in
patients with adenocarcinomas, and predict response to
TK Inhibitors (TKIs).
Sections of adenocarcinomas of the lung, formalin-
fixed paraffin-embedded tissues (FFPE), were selected to
analyze mutations in EGFR exons 19 and 21 by DNA
extraction for polymerase chain reaction (PCR). Exon 19
was studied by fragment analysis and exon 21 was stu-
died by direct sequencing. The analysis of FISH results
was done by Cappuzzo’ss c o r et oEGFR gene. Determi-
nation of EGFR protein expression was done by immu-
nohistochemistry (IHC) (Zymed Laboratories).
The author’s present two cases of lung adenocarci-
noma that harbours coexisting EGFR exon 19 and 21
mutations and one case of EGFR multiple in frame-
deletions. The patients were female (n = 3), with mixed
type adenocarcinoma overexpressing EGFR by IHC.
Most reports demonstrate one EGFR mutation per
adenocarcinoma. We demonstrated that a single adeno-
carcinoma can harbour more than one EGFR activating
mutations.
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